Three short consecutive PCNE (also known as the Phoenix TV) reports on the GP-TCM Final Conference, the GP-TCM Congress held in Kerkrade and Leiden in mid-April 2012, respectively, and the newly launched GP-TCM Research Association.
In episode one (between minutes 0:00 – 2:16):
It introduces the FP7 GP-TCM project in the background of the recent European Legislation on herbal products. In particular, it featured both the GP-TCM Final Conference held in Kerkrade, the Netherlands on 12th – 13th April 2012 and the GP-TCM Congress held in Leiden, the Netherlands on 16th – 18th April 2012, where the GP-TCM Research Association was officially launched.
Dr. Qihe Xu (King’s College London, UK), the FP7 GP-TCM project Coordinator was interviewed in Chinese. He commented that, at the beginning of our project, TCM research was scattered around Europe; now, with the GP-TCM consortium, a large network comprising more than 200 principal investigators from more than 100 institutions (including 20% companies) in over 20 countries has been established.
Dr. Tai-Ping Fan (University of Cambridge, UK), General Secretary of the newly launched GP-TCM Research Association, added in Chinese “with support from so many friends, give us another three years, we will make an even bigger difference”.
In episode two (shown between minutes 2:17 – 5:39):
Professor Jingyan Han (Peking University, China), a GP-TCM non-beneficiary member who attended both meetings, was interviewed in Chinese. He used his poster presentation at the Leiden Congress as an example to illustrate how TCM can be used to treat stroke, a major killer in Europe.
Professor Rudolf Bauer (University of Graz, Austria), Founding President of the GP-TCM Research Association, explained (in English) the mission and objectives of the newly launched Association and call on interested parties to join the epic efforts by the GP-TCM consortium and the new Association.
Professor Xioamin Wang (China Capital Medical University, China), the WP8 Co-Coordinator of the GP-TCM Consortium, was interviewed in Chinese. He stressed the importance of TCM modernisation and internationalisation and commented on the role for the GP-TCM consortium in this process.
In episode three (shown between minutes 5:40 – 8:36):
Professor Peter Hylands (King’s College London, UK), WP4 Coordinator and Chairman of the Technological Advisory Board of the FP7 GP-TCM project, answered TV interview in English. He explained that Chinese herbal medicine is an invaluable resource and TCM uses a very different philosophy than Western medicine. These, if combined with emerging technology, could be major sources of important medical discoveries. That’s why people in Europe (including himself) are interested in TCM.
Professor De-an Guo (Chinese Academy of Sciences, China), President-Elect of the GP-TCM Research Association, explained (in Chinese) that funding is no longer a major issue (in China) to TCM; the key in the future is to conduct high-quality, internationally recognised research to show how Chinese herbal medicines work as drugs, thus consolidating the scientific base for TCM.